BIOMAT Database Logo BIOMAT Database Logo

[Pyridonecarboxylic acids as antibacterial agents. IV. Synthesis and structure-activity relationship of 7-amino-1-aryl-6-fluoro-4-quinolone-3-carboxylic acids]. 1986

H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa

UI MeSH Term Description Entries
D008297 Male Males
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000634 Aminoquinolines Quinolines substituted in any position by one or more amino groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
Pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and structure-activity relationship of 7-(alkyl, cycloalkyl, and vinyl)-1-cyclopropyl-6-fluoro-4-quinolone-3-carboxylic acids.
October 1994, Chemical & pharmaceutical bulletin,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
Pyridonecarboxylic acids as antibacterial agents. VII. Synthesis and structure-activity relationship of amino- and hydroxyl-substituted 7-cycloalkyl and 7-vinyl derivatives of 1-cyclopropyl-6-fluoro-4-quinolone-3- carboxylic acid.
October 1994, Chemical & pharmaceutical bulletin,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
Pyridonecarboxylic acids as antibacterial agents. 9. Synthesis and antibacterial activity of 1-substituted 6-fluoro-1,4-dihydro-4-oxo-7-(4-pyridyl)-1,8-naphthyridine-3- carboxylic acids.
September 1987, Journal of medicinal chemistry,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
Pyridonecarboxylic acids as antibacterial agents. VIII. Synthesis and structure-activity relationship of 7-(1-aminocyclopropyl)-4-oxo-1,8-naphthyridine-3-carboxylic acids and 7-(1-aminocyclopropyl)-4-oxoquinoline-3-carboxylic acids.
October 1994, Chemical & pharmaceutical bulletin,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
[Studies on pyridonecarboxylic acids as antibacterial agents. X. Synthesis and structure-activity relationships of 1, 7-disubstituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acids].
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
Pyridonecarboxylic acids as antibacterial agents. 4. Synthesis and antibacterial activity of 7-(3-amino-1-pyrrolidinyl)-1-ethyl-6-fluoro-1,4 -dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and its analogues.
December 1984, Journal of medicinal chemistry,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
[Studies on pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and antibacterial activity of 7-chloro-6-fluoro-1-ethyt-1, 4-dihydro-4-oxopyrido(2,3-c)pyridazine-3-carboxylic acid and derivatives].
January 1988, Yao xue xue bao = Acta pharmaceutica Sinica,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
[Studies on pyridonecarboxylic acids as antibacterial agents. VIII. Synthesis and structure-activity relationships of 1-(P-fluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl) cinnoline-3-carboxylic acid and analogues].
January 1989, Yao xue xue bao = Acta pharmaceutica Sinica,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
[Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
November 1997, Yao xue xue bao = Acta pharmaceutica Sinica,
H Narita, and Y Konishi, and J Nitta, and H Nagaki, and Y Kobayashi, and Y Watanabe, and S Minami, and I Saikawa
Studies on pyridonecarboxylic acids. IV. Synthesis and antibacterial activity evaluation of S-(-)- and R-(+)-6-fluoro-1-methyl-4-oxo-7- (1-piperazinyl)-4H-[1,3] thiazeto[3,2-a]quinoline-3-carboxylic acids.
July 1995, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!